HUBS vs LFCR · P/E 96, rev $1.79B vs rev $75.5M
HubSpot Inc (HUBS) versus Lifecore Biomedical Inc. (LFCR) — a side-by-side from cached financials, not a winner call.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported HUBS revenue for 2026-06-30 was $1.79B. Net income was $75.9M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
Latest reported LFCR revenue for 2025-12-31 was $75.5M. Net income was -$18.0M. Revenue was up 771.6% from 2025-06-30 to 2025-12-31. LFCR currently screens at market cap $207.1M.
HUBS currently screens at market cap $9.36B and trailing P/E 96.2. LFCR currently screens at market cap $207.1M.
Not investment advice. Open the HUBS and LFCR stock pages for the full models.
Not investment advice.